{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:45:46Z","timestamp":1772606746659,"version":"3.50.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1677,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1111\/j.1365-2133.2010.09976.x","type":"journal-article","created":{"date-parts":[[2010,8,13]],"date-time":"2010-08-13T00:16:25Z","timestamp":1281658585000},"page":"238-244","source":"Crossref","is-referenced-by-count":57,"title":["Compliance with pregnancy prevention programmes of isotretinoin in Europe: a systematic review"],"prefix":"10.1093","volume":"164","author":[{"given":"H.J.M.J.","family":"Crijns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Straus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gispen-de Wied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.T.W.","family":"de Jong-van den Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,1,28]]},"reference":[{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0140-6736(83)90538-X","article-title":"Teratogenicity of isotretinoin","volume":"322","author":"Rosa","year":"1983","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJM198510033131401","article-title":"Retinoic acid embryopathy","volume":"313","author":"Lammer","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJM199507133330206","article-title":"A pregnancy-prevention program in women of childbearing age receiving isotretinoin","volume":"333","author":"Mitchell","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB4|cit4","first-page":"28","article-title":"Accutane-exposed pregnancies - California, 1999","volume":"49","author":"Centers of Disease Control","year":"2000","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/archderm.141.5.563","article-title":"Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program","volume":"141","author":"Brinker","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB6|cit6","first-page":"518","article-title":"Isotr\u00e9tino\u00efne (Roaccutane) chez la femme en \u00e2ge de procr\u00e9er: insuffisance de suivi des recommandations de prescription","volume":"124","author":"Autret","year":"1997","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB7|cit7","first-page":"808","article-title":"Roaccutane chez la femme en \u00e2ge de procr\u00e9er: \u00e9tude de l\u2019impact du renforcement des recommandations de prescription","volume":"127","author":"Autret-Leca","year":"2000","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0151-9638(05)79302-9","article-title":"Isotr\u00e9tino\u00efn: suivi de l\u2019application des recommandations des prescriptions chez les femmes en \u00e2ge de procr\u00e9er","volume":"132","author":"Bensouda-Grimaldi","year":"2005","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1046\/j.1365-2133.1998.02123.x","article-title":"The prescription of isotretinoin to women: is every precaution taken?","volume":"138","author":"Holmes","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1096-9926(199908)60:2<53::AID-TERA2>3.0.CO;2-7","article-title":"Restriction of the use of drugs with teratogenic properties: Swedish experiences with isotretinoin","volume":"60","author":"K\u00e4ll\u00e9n","year":"1999","journal-title":"Teratology"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/09546630260199532","article-title":"Isotretinoin in Denmark - 20\u2003years on","volume":"13","author":"Wildfang","year":"2002","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB12|cit12","first-page":"589","article-title":"Modalit\u00e9s de prescription et de surveillance de l\u2019isotr\u00e9tino\u00efne den C\u00f4te d\u2019Or: \u00e9tude prospective chez 67 femmes en \u00e2ge de procr\u00e9er","volume":"23","author":"Dutronc","year":"2004","journal-title":"Nouv Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ypmed.2007.04.010","article-title":"The need for restricted prescription of retinoid acid derivative isotretinoin to prevent retinoid teratogenicity","volume":"45","author":"De Santis","year":"2007","journal-title":"Prev Med"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.annder.2008.11.015","article-title":"Aide au bon usage de l\u2019isotr\u00e9tino\u00efn en pratique lib\u00e9rale: observatoire prospectif de 1263 patients acn\u00e9iques","volume":"136","author":"Jeanmougin","year":"2009","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00404-009-1112-2","article-title":"Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy","volume":"281","author":"Schaefer","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000264234","article-title":"Fetal tissue dosages of retinoid. Experimental study concerning a case of isotretinoin (Roaccutan) administration and pregnancy","volume":"10","author":"Benifla","year":"1995","journal-title":"Fetal Diagn Ther"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB17|cit17","first-page":"274","article-title":"Dosages maternels et foetaux de r\u00e9tino\u00efdes. A propos de 2 cas d\u2019exposition \u00e0 l\u2019isotr\u00e9tino\u00efne (Roaccutane\u00ae)","volume":"25","author":"Pons","year":"1996","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/pd.1970120812","article-title":"Morphological features of a case of retinoic acid embryopathy","volume":"12","author":"Van Maldergem","year":"1992","journal-title":"Prenat Diagn"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB19|cit19","first-page":"43","article-title":"T\u00e9ratog\u00e9nicit\u00e9 des r\u00e9tino\u00efdes. Un cas et revue de la litt\u00e9rature","volume":"22","author":"Heckel","year":"1993","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB20|cit20","first-page":"511","article-title":"Embryopathie li\u00e9e \u00e0 l\u2019isotretino\u00efne (Roaccutane\u00ae). A propos d\u2019une observation","volume":"24","author":"Pilorget","year":"1995","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0929-693X(98)80112-7","article-title":"T\u00e9ratog\u00e9nicit\u00e9 de l\u2019isotr\u00e9tino\u00efne","volume":"5","author":"Dos Santos","year":"1998","journal-title":"Arch P\u00e9diatr"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB22|cit22","first-page":"78","article-title":"Isotretinoin (Ro-Accutane) teratogenesis. A case report","volume":"32","author":"Giannoulis","year":"2005","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1111\/j.1365-2133.2010.09976.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1365-2133.2010.09836.x","article-title":"Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010","volume":"162","author":"Goodfield","year":"2010","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.09976.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2010.09976.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:49:48Z","timestamp":1676382588000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/164\/2\/238\/6643889"}},"subtitle":["Isotretinoin in Europe, a review"],"short-title":[],"issued":{"date-parts":[[2011,1,28]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09976.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,28]]}}}